TerrAscend (TSNDF) EPS (Weighted Average and Diluted) (2021 - 2026)
TerrAscend (TSNDF) reported EPS (Weighted Average and Diluted) of -$0.03 for Q1 2026, little changed year-over-year from -$0.03 in Q1 2025, and down 115.0% quarter-over-quarter from $0.2 in Q4 2025.
TerrAscend (TSNDF) EPS (Weighted Average and Diluted) (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 6 years of EPS (Weighted Average and Diluted) data on file, last reported at -$0.03 in Q1 2026.
- EPS (Weighted Average and Diluted) for Q1 2026 came in at -$0.03, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $0.1 (up 143.48% YoY), and the FY2025 annual result was -$0.1, up 64.29% from the prior year.
- EPS (Weighted Average and Diluted) fell to -$0.03 in Q1 2026 per TSNDF's latest filing, from $0.2 in the prior quarter.
- Over five years, EPS (Weighted Average and Diluted) peaked at $0.2 in Q4 2025 and troughed at -$1.19 in Q3 2022.
- A 5-year average of -$0.09 and a median of -$0.04 in 2023 frame the typical range for EPS (Weighted Average and Diluted).
- The sharpest annual moves came in 2022 and 2025: EPS (Weighted Average and Diluted) sank 576.0% in 2022, then jumped 281.82% in 2025.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.09 in 2022, then jumped by 166.67% to $0.06 in 2023, then tumbled by 283.33% to -$0.11 in 2024, then jumped by 281.82% to $0.2 in 2025, then slumped by 115.0% to -$0.03 in 2026.
- Business Quant data shows TSNDF's EPS (Weighted Average and Diluted) at -$0.03 in Q1 2026, $0.2 in Q4 2025, and -$0.04 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 0.31 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 1.42 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 5.82 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 0.02 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.91 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 0.11 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -0.40 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -0.40 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.80 |
| 10 | TerrAscend | - | - | 34.60 Mn | -0.03 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.03 |
| Dec 31, 2025 | 0.20 |
| Sep 30, 2025 | -0.04 |
| Jun 30, 2025 | -0.03 |
| Mar 31, 2025 | -0.03 |
| Dec 31, 2024 | -0.11 |
| Sep 30, 2024 | -0.06 |
| Jun 30, 2024 | -0.03 |
| Mar 31, 2024 | -0.06 |
| Dec 31, 2023 | 0.06 |
| Sep 30, 2023 | -0.04 |
| Jun 30, 2023 | -0.05 |
| Mar 31, 2023 | -0.08 |
| Dec 31, 2022 | -0.09 |
| Sep 30, 2022 | -1.19 |
| Jun 30, 2022 | 0.06 |
| Mar 31, 2022 | -0.07 |
| Dec 31, 2021 | 0.03 |
| Sep 30, 2021 | 0.25 |
| Jun 30, 2021 | -0.17 |